Shehadeh Naim相关文献与解析，生知库 | 链接生命科学的每一步

Glucagon-like peptide-1 receptor agonists in adults with cystic fibrosis-related diabetes: Rationale and emerging evidence

胰高血糖素样肽-1受体激动剂在囊性纤维化相关糖尿病成人患者中的应用：理论基础和最新证据

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.16516

Assalia Naffa, Mai; Ayada, Gida; Zolotov, Sagit; Shehadeh, Naim; Nakhleh, Afif

Apelin and Myostatin Levels in Adolescents With Type-1-Diabetes

1型糖尿病青少年体内Apelin和Myostatin水平

期刊:Pediatric Diabetes

影响因子:5.6

doi:10.1155/pedi/1578938

Cohen, Michal; Weiss, Lotem; Weiss, Ram; Shehadeh, Naim; Khamaisi, Mogher

Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up)

达格列净或沙格列汀治疗2型糖尿病儿童的安全性、生长和发育情况（T2NOW随访）

期刊:Journal of Clinical Endocrinology & Metabolism

影响因子:5.1

doi:10.1210/clinem/dgae723

Shehadeh, Naim; Galassetti, Pietro; Iqbal, Nayyar; Karlsson, Cecilia; Monyak, John; Ostridge, Jennifer; Bolin, Marie; Barrett, Timothy

Analysis and Visualization of Confounders and Treatment Pathways Leading to Amputation and Non-Amputation in Peripheral Artery Disease Patients Using Sankey Diagrams: Enhancing Explainability

利用桑基图分析和可视化外周动脉疾病患者截肢和非截肢的混杂因素和治疗路径：增强可解释性

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines13020258

Korutla, Rajashekar; Tedder, Douglas; Brogan, Kathryn; Milosevic, Marko; Wilczek, Michael P; Shehadeh, Naim; Shara, Nawar; Ross, Elsie G; Amal, Saeed

发表日期：2025

文献求助收藏

Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease

在患有 2 型糖尿病和慢性肾病的患者中，非奈利酮联合 SGLT2 抑制剂和 GLP-1 受体激动剂治疗的真实世界疗效

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm14228209

Nakhleh, Afif; Khazim, Khaled; Shehadeh, Naim

Remission of type 2 diabetes mellitus

2型糖尿病缓解

期刊:World Journal of Diabetes

影响因子:4.6

doi:10.4239/wjd.v15.i7.1384

Nakhleh, Afif; Halfin, Elya; Shehadeh, Naim

GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism

GLP-1受体激动剂可能增强去氨加压素对AVP缺乏症患者的疗效：病例系列研究及机制探讨

期刊:Pituitary

影响因子:3.4

doi:10.1007/s11102-024-01451-7

Nakhleh, Afif; Shehadeh, Naim; Mansour, Bshara

Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review

钠-葡萄糖协同转运蛋白2抑制剂对斋月期间禁食的2型糖尿病患者血糖控制的安全性和有效性：一项综述

期刊:Clinical Medicine Insights-Endocrinology and Diabetes

影响因子:3

doi:10.1177/11795514241238058

Nakhleh, Afif; Mazareeb, Jomana; Darawshi, Said; Masri, Amin; Shehadeh, Naim

Treatment of Youth-Onset Type 2 Diabetes: Focus on SGLT-2 Inhibitor Use

青少年发病型2型糖尿病的治疗：重点关注SGLT-2抑制剂的使用

Clinical and biochemical profile of individuals with renal glucosuria: A matched cohort study

肾性糖尿患者的临床和生化特征：一项匹配队列研究

Glucagon-like peptide-1 receptor agonists in adults with cystic fibrosis-related diabetes: Rationale and emerging evidence

胰高血糖素样肽-1受体激动剂在囊性纤维化相关糖尿病成人患者中的应用：理论基础和最新证据

Apelin and Myostatin Levels in Adolescents With Type-1-Diabetes

1型糖尿病青少年体内Apelin和Myostatin水平

Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up)

达格列净或沙格列汀治疗2型糖尿病儿童的安全性、生长和发育情况（T2NOW随访）

Analysis and Visualization of Confounders and Treatment Pathways Leading to Amputation and Non-Amputation in Peripheral Artery Disease Patients Using Sankey Diagrams: Enhancing Explainability

利用桑基图分析和可视化外周动脉疾病患者截肢和非截肢的混杂因素和治疗路径：增强可解释性

Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease

在患有 2 型糖尿病和慢性肾病的患者中，非奈利酮联合 SGLT2 抑制剂和 GLP-1 受体激动剂治疗的真实世界疗效

Remission of type 2 diabetes mellitus

2型糖尿病缓解

GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism

GLP-1受体激动剂可能增强去氨加压素对AVP缺乏症患者的疗效：病例系列研究及机制探讨

Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review

钠-葡萄糖协同转运蛋白2抑制剂对斋月期间禁食的2型糖尿病患者血糖控制的安全性和有效性：一项综述